Alpha Tau Medical Ltd.

4.0900-0.11 (-2.62%)

Oct 29, 4:00:02 PM EDT · NasdaqCM · DRTS · USD

Upcoming Earnings

Report date

≈ Nov 19, 2025 (in 20 days)

Key Stats

Market Cap

347.83M

P/E (TTM)

Basic EPS (TTM)

-0.48

Dividend Yield

About

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.

CEO

Mr. Uzi Sofer

IPO

3/8/2021

Website

https://www.alphatau.com

Employees

125

Sector

Healthcare

Industry

Biotechnology